Differences in Neuropathology between Nitroglycerin-Induced Mouse Models of Episodic and Chronic Migraine

Songyi Park,Harry Jung,Sang-Won Han,Sang-Hwa Lee,Jong-Hee Sohn,Park,Jung,Han,Lee,Sohn

DOI: https://doi.org/10.3390/ijms25073706

IF: 5.6

2024-03-27

International Journal of Molecular Sciences

Abstract:Multiple animal models of migraine have been used to develop new therapies. Understanding the transition from episodic (EM) to chronic migraine (CM) is crucial. We established models mimicking EM and CM pain and assessed neuropathological differences. EM and CM models were induced with single NTG or multiple injections over 9 days. Mechanical hypersensitivity was assessed. Immunofluorescence utilized c-Fos, NeuN, and Iba1. Proinflammatory and anti-inflammatory markers were analyzed. Neuropeptides (CGRP, VIP, PACAP, and substance P) were assessed. Mechanical thresholds were similar. Notable neuropathological distinctions were observed in Sp5C and ACC. ACC showed increased c-Fos and NeuN expression in CM (p < 0.001) and unchanged in EM. Sp5C had higher c-Fos and NeuN expression in EM (p < 0.001). Iba1 was upregulated in Sp5C of EM and ACC of CM (p < 0.001). Proinflammatory markers were strongly expressed in Sp5C of EM and ACC of CM. CGRP expression was elevated in both regions and was higher in CM. VIP exhibited higher levels in the Sp5C of EM and ACC of CM, whereas PACAP and substance P were expressed in the Sp5C in both models. Despite similar thresholds, distinctive neuropathological differences in Sp5C and ACC between EM and CM models suggest a role in the EM to CM transformation.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore the neuropathological differences between the nitroglycerin (NTG)-induced episodic migraine (EM) and chronic migraine (CM) models in mice.

Specifically:
1. **Model Establishment**: Establish EM and CM models through single or multiple injections of NTG, respectively.
2. **Assessment of Mechanical Hypersensitivity**: Evaluate mechanical hypersensitivity in both models.
3. **Neural Activation Analysis**: Assess the expression of c-Fos and NeuN in the spinal trigeminal nucleus caudalis (Sp5C) and anterior cingulate cortex (ACC).
4. **Microglial Activation**: Evaluate the expression of Iba1 in Sp5C and ACC.
5. **Inflammatory Markers**: Analyze pro-inflammatory and anti-inflammatory markers (such as IL-1β, IL-6, TNF-α, etc.) in Sp5C and ACC.
6. **Neuropeptide Expression**: Assess the expression levels of several neuropeptides (such as CGRP, VIP, PACAP, Substance P) in Sp5C and ACC.

The study found significant neuropathological differences between the EM and CM models in Sp5C and ACC, which help in understanding the mechanisms of transformation from EM to CM.